FormWeb • methocarbamol

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

methocarbamol

methocarbamol

Formulary Miscellaneous Programs

Drug Name	Form	Strength
Robaxin	SOLUTION, INJECTABLE	100 mg/mL
Robaxin	TABLET, ORAL	500 mg
Robaxin-750	TABLET, ORAL	750 mg

VIEW MORE Centrally Acting Skeletal Muscle Relaxants

Comments:

Pharmacists may convert IV to PO on a 1 mg to 1 mg as below:

Ordered dose	PO conversion
1,000 mg IV every 8 hours	1,000 mg PO every 6 hours

If insufficient muscle pain or spasm control and if methocarbamol IV was administer for < 3 days:

methocarbamol PO dose may be increased to 1,500 mg q6hr for up to 3 days

and then reduced to 1,500 mg q8hr or 1,000 mg q6hr

Updated: 23 Feb 2016 (methocarbamol tablet)

Last updated: May. 9, 2017

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.